Savvy Updates, 3/20/23: Vertex Cleared for VX-264 Trials, Nemaura Medical & SugarBeat, Insulin Leads to Smaller Pancreas, Insulet Joins S&P500, Insulin Costs & Price Cuts, Sanofi Buys ProventionBio

Savvy Updates, 3/20/23: Vertex Cleared for VX-264 Trials, Nemaura Medical & SugarBeat, Insulin Leads to Smaller Pancreas, Insulet Joins S&P500, Insulin Costs & Price Cuts, Sanofi Buys ProventionBio

New Vertex Type 1 Stem Cell Therapy Gets FDA Nod to Enter Clinical Trials by Andrew Briskin for diaTribe.org, 9 March 2023.   The FDA announced that a new type 1 diabetes stem cell therapy from Vertex has been cleared to enter clinical trials in the United...
Skip to content